Michael Dall

740 total citations
12 papers, 511 citations indexed

About

Michael Dall is a scholar working on Cardiology and Cardiovascular Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Michael Dall has authored 12 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Gastroenterology and 3 papers in Surgery. Recurrent topics in Michael Dall's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (4 papers). Michael Dall is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (4 papers). Michael Dall collaborates with scholars based in Denmark, United States and Russia. Michael Dall's co-authors include Jesper Hallas, Annmarie Touborg Lassen, Alin Andries, Birthe Søgaard Andersen, Claus Aalykke, Morten Andersen, Ove B. Schaffalitzky de Muckadell, Ole K. Bonderup, Gunnar Lauge Nielsen and Anton Pottegård and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Clinical Gastroenterology and Hepatology and British Journal of Clinical Pharmacology.

In The Last Decade

Michael Dall

12 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Dall Denmark 8 261 185 153 91 79 12 511
Claus Aalykke Denmark 8 216 0.8× 253 1.4× 220 1.4× 79 0.9× 90 1.1× 20 522
Nicholas B. Norgard United States 14 213 0.8× 92 0.5× 26 0.2× 38 0.4× 59 0.7× 31 413
Emma Nauclér Sweden 14 219 0.8× 559 3.0× 443 2.9× 79 0.9× 136 1.7× 33 783
Birthe Søgaard Andersen Denmark 8 304 1.2× 143 0.8× 103 0.7× 73 0.8× 58 0.7× 14 520
Ignacio Ferreira Spain 14 517 2.0× 274 1.5× 43 0.3× 161 1.8× 103 1.3× 31 846
Aarti A. Patel United States 12 186 0.7× 51 0.3× 13 0.1× 16 0.2× 58 0.7× 40 411
Michael P. Delaney United Kingdom 14 121 0.5× 83 0.4× 15 0.1× 91 1.0× 14 0.2× 24 686
Herbert Noack Germany 19 1.0k 4.0× 124 0.7× 27 0.2× 53 0.6× 19 0.2× 40 1.3k
Laura Peeters Netherlands 12 103 0.4× 121 0.7× 96 0.6× 33 0.4× 12 0.2× 29 437
D Conen Switzerland 7 237 0.9× 71 0.4× 7 0.0× 35 0.4× 12 0.2× 24 424

Countries citing papers authored by Michael Dall

Since Specialization
Citations

This map shows the geographic impact of Michael Dall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dall more than expected).

Fields of papers citing papers by Michael Dall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Dall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dall. The network helps show where Michael Dall may publish in the future.

Co-authorship network of co-authors of Michael Dall

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Dall. A scholar is included among the top collaborators of Michael Dall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Dall. Michael Dall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Petersen, Jóhanna, et al.. (2019). A model to predict the risk of aspirin/non‐steroidal anti‐inflammatory drugs‐related upper gastrointestinal bleeding for the individual patient. Basic & Clinical Pharmacology & Toxicology. 126(5). 437–443. 7 indexed citations
2.
Bonderup, Ole K., Gunnar Lauge Nielsen, Michael Dall, Anton Pottegård, & Jesper Hallas. (2018). Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case‐control study. Alimentary Pharmacology & Therapeutics. 48(6). 618–625. 36 indexed citations
3.
Bonderup, Ole K., Gunnar Lauge Nielsen, Michael Dall, Anton Pottegård, & Jesper Hallas. (2017). P720 Use of proton pump inhibitors associated with a markedly increased risk of microscopic colitis. Journal of Crohn s and Colitis. 11(suppl_1). S448–S449. 1 indexed citations
4.
Dall, Michael, et al.. (2014). The Association between Use of Serotonergic Antidepressants and Perioperative Bleeding during Total Hip Arthroplasty – A Cohort Study. Basic & Clinical Pharmacology & Toxicology. 115(3). 277–281. 14 indexed citations
5.
Dall, Michael, René dePont Christensen, Ove B. Schaffalitzky de Muckadell, Annmarie Touborg Lassen, & Jesper Hallas. (2012). Re‐prescribing of causative drugs in persons discharged after serious drug‐induced upper gastrointestinal bleeding. Alimentary Pharmacology & Therapeutics. 35(8). 948–954. 3 indexed citations
6.
Dall, Michael, et al.. (2011). Helicobacter pyloriand risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors. Scandinavian Journal of Gastroenterology. 46(9). 1039–1044. 13 indexed citations
7.
Dall, Michael, Ove B. Schaffalitzky de Muckadell, Annmarie Touborg Lassen, & Jesper Hallas. (2010). There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population‐based case–control study. Alimentary Pharmacology & Therapeutics. 32(11-12). 1383–1391. 22 indexed citations
8.
Dall, Michael, et al.. (2009). An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology. 7(12). 1314–1321. 83 indexed citations
9.
Gülmez, Sinem Ezgi, Annmarie Touborg Lassen, Claus Aalykke, et al.. (2009). Do statins protect against upper gastrointestinal bleeding?. British Journal of Clinical Pharmacology. 67(4). 460–465. 17 indexed citations
10.
Gülmez, Sinem Ezgi, Annmarie Touborg Lassen, Claus Aalykke, et al.. (2008). Spironolactone use and the risk of upper gastrointestinal bleeding: a population‐based case–control study. British Journal of Clinical Pharmacology. 66(2). 294–299. 23 indexed citations
11.
Hallas, Jesper, Michael Dall, Alin Andries, et al.. (2007). [Use of anti-thrombotic agents--monotherapy or combination and risk of upper gastrointestinal bleedings: a population-based case-control study. Secondary publication].. PubMed. 169(17). 1577–9. 2 indexed citations
12.
Hallas, Jesper, Michael Dall, Alin Andries, et al.. (2006). Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 333(7571). 726–726. 290 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026